US Market Report for Shaver Blades 2017 - MedCore is a new market research publication announced by Reportstack.
General Report Contents• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
In 2016, the shaver blade market was valued at over $260 million, a modest increase over the previous year. Growth was driven by an uptick in units sold, while prices remained relatively stable. The total shaver blade market includes two segments: (1) the disposable shaver blade segment and (2) the reprocessed shaver blade segment.
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
In 2016, the shaver blade market was valued at over $260 million, a modest increase over the previous year. Growth was driven by an uptick in units sold, while prices remained relatively stable. The total shaver blade market includes two segments: (1) the disposable shaver blade segment and (2) the reprocessed shaver blade segment.
Complete report available @ US Market Report for Shaver Blades 2017 - MedCore
Reprocessed blades are disposable blades that have been reprocessed to sharpen the blade. Reprocessed blades are re-sold at a lower price than a new disposable blade. The difficulty in reprocessing shaver blades involves sterilization and quality control. Furthermore, reprocessed shaver blades are not as sharp as new disposable ones. Surgeons may encounter problems with operating on some patients who have higher bone density than others. Most surgeons prefer disposable shavers over reprocessed shavers in the United States.
In 2016, about 75% of total arthroscopic procedures were performed in the ASC setting. However, ASCs generally have a smaller budget compared to hospitals, and are therefore more price-sensitive. Reprocessed blades are more popular in smaller clinics and surgical centers due to their low average selling prices.
In 2016, about 75% of total arthroscopic procedures were performed in the ASC setting. However, ASCs generally have a smaller budget compared to hospitals, and are therefore more price-sensitive. Reprocessed blades are more popular in smaller clinics and surgical centers due to their low average selling prices.
Scope
2013-2023
2013-2023
Companies Mentioned
Smith & Nephew Arthrex Stryker ConMed Linvatec DePuy Mitek Karl Storz Zimmer Biomet Richard Wolf Others include: Ackermann, Cannuflow, Ceterix Orthopaedics, Gateway Medical, HNM Medical, Integrated Endoscopy, Karl Storz, Medifix, MediVision, Medline, Medtronic, Millennium Surgical, OrthoMed, Parcus Medical, Richard Wolf, RoG Sports Medicine, Sklar, Sopro Comeg, SterilMed, Stryker, Tornier, Velocity Orthopedics, etc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment